NOS2 and neoplasm: We previously demonstrated that NOS inhibition with the pan-NOS inhibitor NG-monomethyl-L-arginine (L-NMMA) decreased tumor cell proliferation, mammosphere formation, and migration in vitro and reduced tumor development and growth as well as lung metastasis in TNBC patient-derived xenograft (PDX) models11,12.